MASSNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
908 Devices Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$11.43+0.17 (+1.51%)
Close on Oct 19, 2026
- Market cap
- $431.23M
- P/E (TTM)
- –
- Dividend yield
- –
908 Devices Inc. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|
| Product revenue | $43.28M | $35.53M | $40.21M | $37.50M | $33.29M | $21.27M | 77.0% | +21.8% |
| Device sales revenue | $36.66M | $31.69M | $33.38M | $28.76M | – | – | 65.2% | +15.7% |
| Recurring revenue | $19.42M | $15.93M | $16.48M | $15.72M | – | – | 34.6% | +21.9% |
| Service and contract revenue | $12.92M | $12.22M | $10.02M | $6.98M | $7.82M | $3.49M | 23.0% | +5.7% |
| Contract revenue | $117.00K | $132.00K | $370.00K | $2.38M | – | – | 0.2% | -11.4% |
| Product and service revenue | – | $59.63M | $50.23M | $44.48M | $41.11M | $24.76M | – | – |
| License and contract revenue | – | – | – | $2.38M | $1.10M | $2.14M | – | – |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|
| United States | $41.25M | $35.65M | $38.17M | $37.59M | $34.78M | – | 73.4% | +15.7% |
| Europe, Middle East and Africa | $10.43M | $9.13M | $9.38M | $6.30M | $4.46M | $2.84M | 18.6% | +14.2% |
| Asia Pacific | $3.00M | $2.10M | $1.83M | $2.89M | $2.24M | $1.88M | 5.3% | +42.5% |
| Americas other | $1.53M | $863.00K | $853.00K | $76.00K | $721.00K | – | 2.7% | +76.7% |
| Americas | – | – | – | – | $35.50M | $22.17M | – | – |
From the segment and revenue-disaggregation notes of 908 Devices's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.